•
Jun 30, 2013

AcelRx Q2 2013 Earnings Report

Total Revenue
$407K
Previous year: $224K
+81.7%
EPS
-$4.4
Previous year: -$0.35
+1157.1%
Gross Profit
$407K
Previous year: $224K
+81.7%
Cash and Equivalents
$21.9M
Previous year: $7.54M
+190.6%
Free Cash Flow
-$9.53M
Previous year: -$4.62M
+106.1%
Total Assets
$40.8M
Previous year: $36.6M
+11.3%

AcelRx

AcelRx